(PharmaNewsWire.Com, May 26, 2017 ) As per the syndicated report published by Market Data Forecast Europe Biopharmaceuticals which is estimated to be USD 37.12 billion in 2016 is poised to reach USD 56.83 billion by 2021, at a CAGR of 8.89% from 2016 to 2021. It can attributed to the factors such as Rising disposable income, Increasing demand for healthcare products, Accessible modernised goods and services, Increasing prevalence of obesity, diabetes and heart diseases and Improving healthcare infrastructure in developing markets. However certain challenges like stringent government laws, Establishment of free zones for foreign countries, improper facilities and lack in skilled personnel must be dealt with to attain the full potential.
To give a brief idea, Biopharmaceuticals Market are all those products related to pharmaceutical drugs which are derived or partially synthesized biological sources. It consists of proteins and nucleic acids which are extracted from indirect biological sources for the purpose of therapeutics or vivo diagnostics.
The first biopharmaceutical product which got an approval was Insulin. Biopharmaceuticals can be classified into hematopoietic growth factors, vaccines, interferon, blood factor, monoclonal antibodies, thrombolytic agent and hormone. The extraction of biopharmaceuticals is essential to characterize physiochemical, applying in clinical purposes and for purification. Among the global pharmaceutical market sales, biopharmaceuticals are the estimated to be the fastest growing market which constitutes of about 8% of the market sales.
Europe Biopharmaceuticals Market is segmented based on product type and therapeutic type as mentioned below for attaining a more granular perspective of the market. In the report each sub segment is provided with Market Size Estimations and Y-o-Y Forecasts. Based on Product Type: Monoclonal Antibodies (mAb) Erythropoietin Biotech Vaccines Recombinant Human (RH) Insulin Granulocyte colony-stimulating factor (G-CSF) Interferon Human growth hormones (HGH) Based on Therapeutic Type: Neurology Infectious diseases Diabetes Oncology Cardiovascular Other Therapeutic Areas
Europe is an amalgamation of major economies like Germany, Spain, Italy, U.K. and France among others to name a few. The report justifies this by offering country wise data for the EU5 countries while taking some other predominant economies into consideration as well (Rest of Europe). As per the study, Germany, France and UK are poised to hold the major market share in this region.
Merck & Co., Inc., F. Hoffmann-La Roche AG, Eli Lilly and Company, Inc., Sanofi, Amgen Inc., AbbVie Inc., Biogen Idec, Bayer AG, Johnson & Johnson Services and Pfizer, Inc.are the major players operating in the Europe Biopharmaceuticals Market. Therefore, the competition among the players is increasing because of technological advancements and end-user preferences.
The Biopharmaceuticals market study offers the following deliverables:
Regional and country-level analysis that provides an innate perspective of European region and the aforementioned countries Meticulously identifying the key areas of market growth by providing market size forecasts and y-o-y estimations at a Segment-level analysis Explanations of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of macro and micro environmental factors that affect the European market presented in the form of PESTLE and Porters Five Forces Analyses Company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview of the key market players operating in the region Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Expertly devised Market Outlook - Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
For more reports related to the Pharmaceuticals Market:
About Market Data Forecast: The publisher of this report Market Data Forecast is well known for the services they render in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering Europe among other regions of the global market as well, that too with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
